The challenge of treating biofilm-associated bacterial infections - PubMed (original) (raw)

Review

The challenge of treating biofilm-associated bacterial infections

J L del Pozo et al. Clin Pharmacol Ther. 2007 Aug.

Abstract

Biofilm formation is a crucial step in the pathogenesis of many subacute and chronic bacterial infections, including foreign body-related infections. Biofilms are difficult to eradicate with conventional antimicrobial agents. Bacterial biofilms have several potential antimicrobial resistance mechanisms. Antimicrobial resistance mechanisms may act concurrently, and in some cases, synergistically. Persister cells play a major role in the tolerance of biofilm bacteria to antimicrobial agents. Understanding the mechanisms involved in biofilm-associated antimicrobial resistance is key to development of new therapeutic strategies.

PubMed Disclaimer

Similar articles

• [Biofilm--still a problem?].
  Skrlin J. Skrlin J. Lijec Vjesn. 2010;132 Suppl 1:24-6. Lijec Vjesn. 2010. PMID: 20715715 Croatian.
• Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
  Smith AW. Smith AW. Adv Drug Deliv Rev. 2005 Jul 29;57(10):1539-50. doi: 10.1016/j.addr.2005.04.007. Adv Drug Deliv Rev. 2005. PMID: 15950314 Review.
• Effect of antibacterials on biofilms.
  Aslam S. Aslam S. Am J Infect Control. 2008 Dec;36(10):S175.e9-11. doi: 10.1016/j.ajic.2008.10.002. Am J Infect Control. 2008. PMID: 19084156
• Survival strategies of infectious biofilms.
  Fux CA, Costerton JW, Stewart PS, Stoodley P. Fux CA, et al. Trends Microbiol. 2005 Jan;13(1):34-40. doi: 10.1016/j.tim.2004.11.010. Trends Microbiol. 2005. PMID: 15639630 Review.
• Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
  Sun F, Qu F, Ling Y, Mao P, Xia P, Chen H, Zhou D. Sun F, et al. Future Microbiol. 2013 Jul;8(7):877-86. doi: 10.2217/fmb.13.58. Future Microbiol. 2013. PMID: 23841634 Review.

Cited by

• pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.
  Horev B, Klein MI, Hwang G, Li Y, Kim D, Koo H, Benoit DS. Horev B, et al. ACS Nano. 2015 Mar 24;9(3):2390-404. doi: 10.1021/nn507170s. Epub 2015 Feb 13. ACS Nano. 2015. PMID: 25661192 Free PMC article.
• Lessons learned and unlearned in periodontal microbiology.
  Teles R, Teles F, Frias-Lopez J, Paster B, Haffajee A. Teles R, et al. Periodontol 2000. 2013 Jun;62(1):95-162. doi: 10.1111/prd.12010. Periodontol 2000. 2013. PMID: 23574465 Free PMC article. Review.
• A coverslip-based technique for evaluating Staphylococcus aureus biofilm formation on human plasma.
  Walker JN, Horswill AR. Walker JN, et al. Front Cell Infect Microbiol. 2012 Mar 27;2:39. doi: 10.3389/fcimb.2012.00039. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919630 Free PMC article.
• Evaluation of the Enterococcus faecalis Biofilm-Associated Virulence Factors AhrC and Eep in Rat Foreign Body Osteomyelitis and In Vitro Biofilm-Associated Antimicrobial Resistance.
  Frank KL, Vergidis P, Brinkman CL, Greenwood Quaintance KE, Barnes AM, Mandrekar JN, Schlievert PM, Dunny GM, Patel R. Frank KL, et al. PLoS One. 2015 Jun 15;10(6):e0130187. doi: 10.1371/journal.pone.0130187. eCollection 2015. PLoS One. 2015. PMID: 26076451 Free PMC article.
• Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence.
  Tang J, Brynildsen MP. Tang J, et al. Nucleic Acids Res. 2023 Feb 22;51(3):1208-1228. doi: 10.1093/nar/gkac1223. Nucleic Acids Res. 2023. PMID: 36631985 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information